2025 has been a challenging year for advocates fighting for equitable access to care, as the CDC’s Advisory Committee on Immunization Practices has upended a legacy of science-based recommendations supported by the research community. In a particularly concerning move, ACIP removed its decades-long recommendation for the proven pediatric hepatitis B vaccine—a decision that puts millions of children at risk of long-term complications from this infectious disease.
Joining us to discuss the implications of ACIP’s latest action, and how advocacy organizations across the country are responding, is Scott Frey, Senior VP of Public Policy and Relations here at the Alliance.